Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Current status of clinical research in India
Dr YK Gupta, Professor and Head, Department of Pharmacology, AIIMS, New Delhi expounds on the measures taken to revive clinical…
Art and science of pharma marketing
Pawan Chaudhary, CMD, Venus Remedies, gives an overview on the evolution of pharma marketing and the need to 'think out of the…
Human insulin market will reach $49,197.3 million in 2020 globally: Persistence Market Research
Asia Pacific to show fast growth rates in the next five years
Moving Over the Contraceptive
As the Indian woman becomes more aware and vocal about her health, are pharma companies gearing up to meet her aspirations? For…
Woman on a mission
An entrepreneur producing quality medicines, Leena Gandhi Tewari, Chairperson, USV, is also a humanitarian striving towards the…
Breakingthrough FDA
As women all across the world grapple with cancer, the oncology space is getting competitive with companies coming up with new…
‘Gender diversity and corporate boards’— Pharma leads the way!
Debabrat Mishra, Director, Hay Group India and Sudakshina Tyagi, Senior Consultant, Hay Group India elaborate on the need for more…
US FDA raises concerns over Lupin’s plant at Pithampur
FDA inspected the plant in January this year and listed six observations on the manufacturing processes at the plant
Lupin and Celon in agreement
Lupin and Celon Pharma have entered into a definitive agreement under which the companies will jointly develop fluticasone/…
Zydus completes phase I studies for its oral HIF inhibitor
The multiple dosing studies are expected to be completed by Q2 2015